Last edition
News about Global Pharma
GACL Flags Off First Consignments of Benzyl Alcohol and Benzaldehyde from New Plant in Dahej
Gujarat Alkalies and Chemicals Limited (GACL) marked another significant milestone on July 5, 2025, flagging off its first consignments of Benzyl Alcohol (BOH) and Benzaldehyde (BCHO) from its newly commissioned Chlorotoluenes plant at Dahej.
Global Pharma | 07/07/2025 | By Manvi | 435
India's pharmaceutical industry is set for exponential growth, with projections reaching USD 130 billion by 2030, said IDMA South VP T. Ravichandiran at the Pharmac South Expo 2025.
Global Pharma | 05/07/2025 | By Manvi | 270
PHARMASEAL and Viedoc Enter into Technical Integration Partnership
PHARMASEAL has announced a technology integration partnership with Viedoc to combine its Engility Trial Management Platform with Viedoc’s EDC solutions, offering life sciences companies a unified, cloud-based ecosystem to streamline clinical trial operations and improve data interoperability.
Global Pharma | 05/07/2025 | By Mrinmoy Dey | 200
FDA Approves Thermo Fisher's Oncomine Dx Express Test as Companion Diagnostic for ZEGFROVY
Thermo Fisher Scientific announced the US Food and Drug Administration (FDA) has approved the Oncomine™ Dx Express Test on the Ion Torrent™ Genexus™ Dx Integrated Sequencer as an in vitro diagnostic (IVD) assay for use as a companion diagnostic (CDx) for Dizal’s ZEGFROVY® (sunvozertinib) and in tumor profiling.
Global Pharma | 05/07/2025 | By Manvi | 163
India, Trinidad and Tobago Sign 6 MoUs to Boost Bilateral Cooperation, Including in Pharma
India has signed six Memoranda of Understanding (MoUs) with Trinidad and Tobago to enhance cooperation across several key sectors, including pharmaceuticals.
Global Pharma | 05/07/2025 | By Manvi | 331
Henlius, HanchorBio Partner to Develop HCB101 for Tumour Immunotherapy
Shanghai Henlius Biotech has entered a strategic partnership with HanchorBio’s subsidiary FBD Biologics to license and develop HCB101, a novel SIRPα-Fc fusion protein for tumour immunotherapy, with exclusive rights in China, Southeast Asia, and MENA.
Global Pharma | 05/07/2025 | By Mrinmoy Dey | 264
Lupin has launched its Ipratropium Bromide Nasal Solution, 0.03 percent and 0.06 percent, in the US market, offering bioequivalent alternatives to Atrovent Nasal Spray for the treatment of rhinorrhea.
Global Pharma | 04/07/2025 | By Mrinmoy Dey | 416
Sunshine Biopharma Enters Canadian Biosimilars Market with Launch of Niopeg
Niopeg is a biosimilar to Neulasta (Pegfilgrastim), a long-acting, pegylated form of recombinant human granulocyte colony-stimulating factor (filgrastim), used to reduce infection risk in cancer patients undergoing chemotherapy.
Global Pharma | 04/07/2025 | By Darshana | 265
Lincoln Pharma's New Khatraj Facility Completes Trial Run
Lincoln Pharmaceuticals Ltd has completed the trial run at its newly built manufacturing facility located at Trimul Estate in Khatraj, Gujarat.
Global Pharma | 04/07/2025 | By Manvi | 367
India, Myanmar Explore Fast-Track Pharma Approvals; MoU Likely at iPHEX 2025
India is currently a major supplier of medicines to Myanmar, meeting nearly 60% of the country’s pharmaceutical needs. The MoU will aim to expand bilateral cooperation in pharma trade and regulatory alignment.
Global Pharma | 04/07/2025 | By Darshana | 181
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy